Navigation Links
Formation Capital to Purchase Haven Healthcare
Date:6/12/2008

Genesis HealthCare(SM) to Manage the Facilities

ATLANTA, June 12 /PRNewswire/ -- Formation Capital, LLC today announced it has signed an agreement to purchase Haven Healthcare, a long-term care provider that operates 27 facilities in five northeastern states. Genesis HealthCare will manage and operate the facilities on behalf of Formation Capital and Senior Care Development, LLC. The agreement is subject to pending regulatory and licensing approvals, and other customary conditions. In addition, the agreement is subject to the satisfactory completion of a due diligence period. The agreement is expected to be finalized on August 1, 2008.

Upon closing, Formation Capital and its partners will own or lease skilled nursing and assisted living facilities formerly owned by Haven and located in the states of Connecticut, Massachusetts, New Hampshire, Rhode Island and Vermont.

Genesis HealthCare, a provider of long-term care services in New England for more than 25 years, is expected to assume management and operational responsibilities for Haven Healthcare's facilities effective August 1, 2008.

Genesis HealthCare operates skilled nursing centers and assisted living residences in 13 eastern states and ranks among top providers for overall customer satisfaction and quality medical care according to national independent research. Furthermore, 37 Genesis Centers in New England have earned the Quality Award from the American Health Care Association (AHCA) and the National Center for Assisted Living (NCAL) in recent years, and 19 Centers received the MyInnerView "Excellence in Action" Award, a national award recognizing a commitment to quality.

"The acquisition of the Haven Healthcare facilities complements our portfolio of healthcare companies and our strategy to meet the growing need for skilled nursing services," says Arnold Whitman, Chief Executive Officer and Co-Chairman of Formation Capital, LLC. "Quality of care and services is a hallmark of Genesis HealthCare. We look forward to working with Genesis to expand the healthcare services we provide to New England patients and their family members."

"Genesis has a strong track record of high-quality care throughout our organization," notes Richard Blinn, Genesis' President of the Northeast Area. "We look forward to working with and supporting all of the dedicated staff members of the Haven Healthcare facilities, with a goal of consistently exceeding our customers' expectations," continues Blinn.

Genesis Healthcare operates more than 200 skilled nursing centers and assisted living residences in 13 eastern states. They also supply contract rehabilitation therapy to more than 700 healthcare providers in 20 states and the District of Columbia. For more information, go to http://www.genesishcc.com.

Formation Capital, LLC invests in senior housing and care and currently is invested in over $3 billion of assets. For more information, go to http://www.formationcapital.com.

Contact:

Jeanne Moore

410-451-8440

Patty McQueen

860-985-3533


'/>"/>
SOURCE Genesis HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. HIV denialists spread misinformation online -- consequences could be deadly; and more
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
5. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
9. Cities Say Restaurant Nutrition Information Crucial in Fighting Obesity
10. Unique role for blood formation gene identified
11. Metropolitan Hosts Informational Meetings in Nassau County
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , ... July 26, 2017 , ... Team Type 1 ... to medicine for everyone affected by diabetes, is excited to announce the 106 college ... Ambassador Program. , Established in 2005, the Team Type 1 Foundation has bestowed ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... dogs and cats has opened in Jupiter. The state of the art ... and class leading treatments with a goal of providing heart patients longer lives. ...
(Date:7/26/2017)... ... 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) ... development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned ... International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues of ...
(Date:7/26/2017)... ... 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores Family Law ... Association’s third Vice President earlier this year. She will serve the membership in this capacity ... President, in accordance with the organization’s by-laws. , Musielak joined the Andrew ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults 65 years or ... ways to improve asthma control in the population are not well described. In a ... Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
Breaking Medicine Technology: